下肢与髂动脉血管内手术中导航辅助与非导航辅助的前瞻性多中心随机临床试验方案
本研究为多中心前瞻性随机确证性试验,比较Vascular Navigation PAD导航辅助与常规血管内手术在外周动脉疾病治疗中的安全性和临床性能。主要终点为对比剂用量,计划随机160例患者按1:1分组,同时评估患者和医生辐射暴露、透视时间及DSA次数等次要终点。
要点
- 导航辅助可能减少DSA次数,从而降低对比剂用量和辐射暴露
- 主要终点为对比剂用量,计划入组160例患者按1:1随机
- 次要终点包括患者和医生辐射剂量、透视时间及DSA次数
核心结论
- 本研究旨在评估Vascular Navigation PAD系统在血管内治疗中减少DSA次数、对比剂用量及辐射暴露的潜力。
研究设计与样本
- 多中心、前瞻性、随机确证性试验,比较导航辅助与常规血管内手术,计划随机160例患者按1:1分组,两家医院各入组40例每组。
关键数值与推荐
- 主要终点为对比剂用量;次要终点包括患者辐射暴露、医生辐射暴露、透视时间及每次介入的DSA次数。
临床怎么用
- 若证实有效,导航辅助可能优化外周动脉疾病血管内治疗中的对比剂使用和辐射防护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular procedures using a mobile C-arm are commonly performed in patients with peripheral artery disease. During these procedures, digital subtraction angiography (DSA) requires intra-arterial administration of contrast agent and exposes both patients and staff to radiation from the C-arm. The Vascular Navigation PAD system (Brainlab, Germany) may reduce the number of DSAs performed and thereby decrease both contrast agent use and radiation exposure. The objective of this study is to evaluate the safety and clinical performance of the Vascular Navigation PAD system compared with standard care in endovascular PAD treatment. The primary aim is to determine whether the device reduces the volume of contrast agent used during lower-extremity procedures. Secondary objectives include assessing patient and physician radiation exposure, patient air kerma, and the device's ability to support accurate endovascular navigation. METHODS: This is a multicenter, prospective, randomized confirmatory trial comparing navigation-assisted procedures with conventional procedures without navigation assistance. Patients allocated to the intervention group will undergo treatment using Vascular Navigation PAD in addition to a mobile C-arm. A total of 160 patients will be randomized in a 1:1 ratio, with 40 patients per group enrolled at each of the two participating hospitals. The primary endpoint is contrast agent volume. Secondary endpoints include patient radiation exposure, physician radiation exposure, fluoroscopy time, and the number of DSAs performed per intervention. DISCUSSION: This study will evaluate whether the Vascular Navigation PAD system can reduce the number of DSAs in endovascular treatment. A reduction in DSAs may lead to lower contrast agent use and reduced radiation exposure for both patients and staff. TRIAL REGISTRATION: The clinical trial is registered at the German Clinical Trials Register (ID: DRKS00035267). Registered on 10.Jan.2025.
引用
- Masius S, Zerwes S, Gombert A, et al. Comparison of endovascular procedures of the lower extremities and iliac arteries with and without navigation assistance Vascular Navigation PAD: study protocol for a prospective multicenter randomized clinical trial. Trials. 2026. PMID: 42298710. doi:10.1186/s13063-026-09841-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。